Surya Pharmaceuticals Ltd. - Research Center
532516 SURYAPHARM Group (Z) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Jun' 15 |
Mar' 14 |
Dec' 13 |
Sep' 13 |
Jun' 13 |
Sales |
0.43 |
1.74 |
0.57 |
4.58 |
5.74 |
Operating profit |
-1.08 |
-11.18 |
-617.09 |
-3.16 |
-3.08 |
Interest |
0.08 |
107.78 |
15.93 |
69.28 |
61.80 |
Gross profit |
-1.16 |
-118.51 |
-632.99 |
-72.44 |
-64.89 |
EPS (Rs) |
-0.83 |
15.28 |
-42.80 |
-4.35 |
-3.97 |
Quarterly
results in details
|
Jun' 15 |
Mar' 14 |
Dec' 13 |
Sep' 13 |
Jun' 13 |
Other income |
- |
0.44 |
0.03 |
- |
- |
Stock adjustment |
- |
1.14 |
571.80 |
6.66 |
6.31 |
Raw material |
- |
0.11 |
41.24 |
-0.03 |
0.22 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
0.22 |
0.25 |
0.87 |
0.35 |
0.50 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
1.30 |
11.42 |
3.74 |
0.77 |
1.80 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
15.61 |
15.62 |
15.67 |
15.67 |
15.67 |
Taxation |
- |
-443.85 |
- |
- |
- |
Net profit / loss |
-16.78 |
309.72 |
-867.83 |
-88.11 |
-80.55 |
Extra ordinary item |
- |
- |
-219.17 |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
20.28 |
20.28 |
20.28 |
20.28 |
20.28 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
1597.14 |
1597.14 |
1597.14 |
1597.14 |
1597.14 |
Agg.of non promotoholding (%) |
78.77 |
78.77 |
78.77 |
78.77 |
78.77 |
OPM (%) |
-251.24 |
-642.37 |
-107844.70 |
-68.96 |
-53.72 |
GPM (%) |
- |
-5430.55 |
-105077.29 |
- |
- |
NPM (%) |
- |
14192.34 |
-144061.82 |
- |
- |